本页面由Tiger Trade Technology Pte. Ltd.提供服务

Axsome Therapeutics, Inc.

166.00
-2.3500-1.40%
盘后:166.000.00000.00%19:30 EDT
成交量:66.30万
成交额:1.11亿
市值:86.95亿
市盈率:-44.05
高:170.80
开:169.50
低:165.02
收:168.35
52周最高:260.19
52周最低:119.20
股本:5,238.08万
流通股本:4,383.14万
量比:0.65
换手率:1.51%
股息:- -
股息率:- -
每股收益(TTM):-3.7685
每股收益(LYR):-3.6821
净资产收益率:-245.10%
总资产收益率:-16.31%
市净率:104.38
市盈率(LYR):-45.08

数据加载中...

2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

重要事件披露

Form 8-K - Current report
2025/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/10

重要事件披露

Form 8-K - Current report
2025/06/10

重要事件披露

Form 8-K - Current report
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

重要事件披露

Form 8-K - Current report
2025/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities